DLGAP4-AS1

Across TCGA pan-cancer cohorts, DLGAP4-AS1 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of DLGAP4-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where DLGAP4-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types DLGAP4-AS1 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, COAD, and KICH are the cancer types where DLGAP4-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP4-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	−0.627	<.001	10	view →
COAD	Female	All	+0.345	<.001	10	view →
KICH	Female	All	−0.678	<.001	9	view →
BRCA	All	III,IV	−0.295	<.001	6	view →
STAD	Male	II,III,IV	+0.430	.002	4	view →
LUSC	Male	III,IV	−0.417	.001	4	view →
CHOL	All	All	+0.511	<.001	3	view →
LIHC	All	All	+0.098	.006	2	view →
READ	All	All	+0.504	.022	1	view →
KIRP	All	III,IV	−0.272	.046	1	view →
HNSC	All	All	+0.094	.024	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

DLGAP4-AS1–THCA

Open the THCA breakdown →